Top

Published in:

Open Access 01-12-2022 | Constipation | Research

Improvement of postoperative quality of life in patients with esophageal squamous cell carcinoma: does tea consumption have a role?

Authors: Juwei Zhang, Shuang Liu, Jianyu Song, Jinsong Zhou, Qiaoyan Zeng, Zheng Lin, Kaili Yu, Suhong Zhang, Minglian Qiu, Yuanmei Chen, Zhijian Hu

Published in: BMC Public Health | Issue 1/2022

Abstract

Background

To investigate the effect of tea consumption on the improvement of postoperative quality of life in male patients with esophageal squamous cell carcinoma (ESCC).

Methods

The quality of life information of 290 male patients with ESCC was collected. The time to deterioration and the number of events in each area of quality of life was calculated by time-to-deterioration (TTD) model. The association between postoperative tea drinking and postoperative quality of life in male ESCC patients was investigated using the Cox proportional risk model.

Results

Postoperative tea-drinking patients experienced delayed TTD in multiple domains, including general health, physical, role, emotional, and cognitive function, fatigue, nausea and vomiting, dyspnea, loss of appetite, constipation, diarrhea, eating problems, difficulty swallowing, choking while swallowing saliva, dry mouth, taste difficulties, coughing, and speech problems. The multivariate Cox regression analysis showed that drinking tea after surgery improved quality of life, including physical function (HR = 0.722, 95% CI: 0.559-0.933), role function (HR = 0.740, 95% CI: 0.557-0.983), eating problems (HR = 0.718, 95% CI: 0.537-0.960), odynophagia (HR = 0.682, 95% CI: 0.492-0.945), trouble swallowing saliva (HR = 0.624, 95% CI: 0.444-0.877), coughing (HR = 0.627, 95% CI: 0.442-0.889) and speech problems (HR = 0.631, 95% CI: 0.441-0.903). Furthermore, the improvement was more significant in patients who drank tea before surgery and continued to drink tea after surgery.

Conclusions

Postoperative tea drinking had a positive effect on delay in clinical deterioration and improvements in multiple functions and symptoms associated with ESCC in men.

Available only for authorised users

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.CrossRefPubMed

Yang T, Hui R, Nouws J, Sauler M, Zeng T, Wu Q. Untargeted metabolomics analysis of esophageal squamous cell cancer progression. J Transl Med. 2022;20:127. https://doi.org/10.1186/s12967-022-03311-z.CrossRefPubMedPubMedCentral

Sheng WG, Assogba E, Billa O, Meunier B, Gagnière J, Collet D, et al. Does baseline quality of life predict the occurrence of complications in resectable esophageal cancer? Surg Oncol. 2022;40:101707. https://doi.org/10.1016/j.suronc.2021.101707.CrossRefPubMed

Mariette C, Markar S, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, et al. Health-related quality of life following hybrid minimally invasive versus open Esophagectomy for patients with esophageal Cancer, analysis of a multicenter, open-label, randomized phase III controlled trial: the MIRO trial. Ann Surg. 2020;271:1023–9. https://doi.org/10.1097/SLA.0000000000003559.CrossRefPubMed

Agirrezabal I, Brennan VK, Colaone F, Shergill S, Pereira H, Chatellier G, et al. Transarterial Radioembolization versus Atezolizumab-bevacizumab in Unresectable hepatocellular carcinoma: a matching-adjusted indirect comparison of time to deterioration in quality of life. Adv Ther. 2022;39:2035–51. https://doi.org/10.1007/s12325-022-02099-0.CrossRefPubMedPubMedCentral

Zhang Y, Yang H, Li S, Li W-D, Wang Y. Consumption of coffee and tea and risk of developing stroke, dementia, and poststroke dementia: a cohort study in the UK biobank. PLoS Med. 2021;18:e1003830. https://doi.org/10.1371/journal.pmed.1003830.CrossRefPubMedPubMedCentral

Chen Y, Cheng S, Dai J, Wang L, Xu Y, Peng X, et al. Molecular mechanisms and applications of tea polyphenols: a narrative review. J Food Biochem. 2021;45:e13910. https://doi.org/10.1111/jfbc.13910.CrossRefPubMed

Chen J, Du Y, Long Y, Tao D, Hu M, Jiang Y, et al. Polyphenols in Ilex latifolia Thunb. Inhibit human lung cancer cell line A549 by regulation of the PI3K-Akt signaling pathway. BMC Complement Med Ther. 2022;22:85. https://doi.org/10.1186/s12906-022-03568-3.CrossRefPubMedPubMedCentral

Ma J, Li P, An L, Zhang T, Li G. Chemoprotective effect of theanine in 1,2-dimethylhydrazine-induced colorectal cancer in rats via suppression of inflammatory parameters. J Food Biochem. 2022;46:e14073. https://doi.org/10.1111/jfbc.14073.CrossRefPubMed

10.

Nechuta S, Shu X-O, Li H-L, Yang G, Ji B-T, Xiang Y-B, et al. Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's health study. Am J Clin Nutr. 2012;96:1056–63. https://doi.org/10.3945/ajcn.111.031419.CrossRefPubMedPubMedCentral

11.

Yuan P, Lin L, Zheng K, Wang W, Wu S, Huang L, et al. Risk factors for gastric cancer and related serological levels in Fujian, China: hospital-based case-control study. BMJ Open. 2020;10:e042341. https://doi.org/10.1136/bmjopen-2020-042341.CrossRefPubMedPubMedCentral

12.

Alam M, Ali S, Ashraf GM, Bilgrami AL, Yadav DK, Hassan MI. Epigallocatechin 3-gallate: from green tea to cancer therapeutics. Food Chem. 2022;379:132135. https://doi.org/10.1016/j.foodchem.2022.132135.CrossRefPubMed

13.

Liu D, Jing X, Cao S, Liu X, Tan X, Jiang H, et al. Impact of drinking Chinese green tea on postoperative short outcomes for gastric cancer: a randomized controlled trial. Eur J Clin Nutr. 2021;75:1568–77. https://doi.org/10.1038/s41430-021-00868-8.CrossRefPubMedPubMedCentral

14.

Mancini E, Beglinger C, Drewe J, Zanchi D, Lang UE, Borgwardt S. Green tea effects on cognition, mood and human brain function: a systematic review. Phytomedicine. 2017;34:26–37. https://doi.org/10.1016/j.phymed.2017.07.008.CrossRefPubMed

15.

Ratajczak AE, Szymczak-Tomczak A, Zawada A, Rychter AM, Dobrowolska A, Krela-Kaźmierczak I. Does drinking coffee and tea affect bone metabolism in patients with inflammatory bowel diseases? Nutrients. 2021. https://doi.org/10.3390/nu13010216.

16.

Kim W, Han K-T, Kim S. Health-related quality of life among cancer patients and survivors and its relationship with current employment status. Support Care Cancer. 2022;30:4547–55. https://doi.org/10.1007/s00520-022-06872-3.CrossRefPubMed

17.

Charton E, Cuer B, Cottone F, Efficace F, Touraine C, Hamidou Z, et al. Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review. Qual Life Res. 2020;29:867–78. https://doi.org/10.1007/s11136-019-02367-7.CrossRefPubMed

18.

Anota A, Barbieri A, Savina M, Pam A, Gourgou-Bourgade S, Bonnetain F, et al. Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study. Health Qual Life Outcomes. 2014;12:192. https://doi.org/10.1186/s12955-014-0192-2.CrossRefPubMedPubMedCentral

19.

Arraras JI, Arias F, Tejedor M, Pruja E, Marcos M, Martínez E, et al. The EORTC QLQ-C30 (version 3.0) quality of life questionnaire: validation study for Spain with head and neck cancer patients. Psychooncology. 2002;11:249–56. https://doi.org/10.1002/pon.555.CrossRefPubMed

20.

Fujita T, Okada N, Sato T, Mayanagi S, Kanamori J, Daiko H. Translation, validation of the EORTC esophageal cancer quality-of-life questionnaire for Japanese with esophageal squamous cell carcinoma: analysis in thoraco-laparoscopic esophagectomy versus open esophagectomy. Jpn J Clin Oncol. 2016;46:615–21. https://doi.org/10.1093/jjco/hyw040.CrossRefPubMed

21.

Hamidou Z, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, Jolly D, et al. Impact of response shift on time to deterioration in quality of life scores in breast cancer patients. PLoS One. 2014;9:e96848. https://doi.org/10.1371/journal.pone.0096848.CrossRefPubMedPubMedCentral

22.

Rasheed Z. Molecular evidences of health benefits of drinking black tea. Int J Health Sci (Qassim). 2019;13:1–3.PubMed

23.

Ano Y, Ohya R, Kita M, Taniguchi Y, Kondo K. Theaflavins improve memory impairment and depression-like behavior by regulating microglial activation. Molecules. 2019. https://doi.org/10.3390/molecules24030467.

24.

Chen S-M, Wang M-H, Soung H-S, Tseng H-C, Fang C-H, Lin Y-W, et al. Neuroprotective effect of l-theanine in a rat model of chronic constriction injury of sciatic nerve-induced neuropathic pain. J Formos Med Assoc. 2022;121:802–14. https://doi.org/10.1016/j.jfma.2021.08.023.CrossRefPubMed

25.

Errachid A, Nohawica M, Wyganowska-Swiatkowska M. A comprehensive review of the influence of epigallocatechin gallate on Sjögren's syndrome associated molecular regulators of exocytosis (review). Biomed Rep. 2021;15:95. https://doi.org/10.3892/br.2021.1471.CrossRefPubMedPubMedCentral

26.

Bond T, Derbyshire E. Tea compounds and the gut microbiome: findings from trials and mechanistic studies. Nutrients. 2019. https://doi.org/10.3390/nu11102364.

27.

Lagergren P, Johar A, Liu Y, Ness-Jensen E, Schandl A. Severe reflux and symptoms of anxiety and depression after esophageal Cancer surgery. Cancer Nurs. 2021. https://doi.org/10.1097/NCC.0000000000001026.

28.

Cao H, Huang X, Zhi X, Han C, Li L, Li Y. Association between tea consumption and gastroesophageal reflux disease: a meta-analysis. Medicine (Baltimore). 2019;98:e14173. https://doi.org/10.1097/MD.0000000000014173.CrossRefPubMed

29.

Bascoul-Mollevi C, Savina M, Anota A, Barbieri A, Azria D, Bonnetain F, et al. Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD. Comput Methods Prog Biomed. 2018;158:153–9. https://doi.org/10.1016/j.cmpb.2018.02.010.CrossRef

30.

Bascoul-Mollevi C, Barbieri A, Bourgier C, Conroy T, Chauffert B, Hebbar M, et al. Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results. Qual Life Res. 2021;30:91–103. https://doi.org/10.1007/s11136-020-02605-3.CrossRefPubMed

Title: Improvement of postoperative quality of life in patients with esophageal squamous cell carcinoma: does tea consumption have a role?
Authors: Juwei Zhang
Shuang Liu
Jianyu Song
Jinsong Zhou
Qiaoyan Zeng
Zheng Lin
Kaili Yu
Suhong Zhang
Minglian Qiu
Yuanmei Chen
Zhijian Hu
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Constipation
Esophageal Cancer
Esophageal Cancer
Constipation
Published in: BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-022-14646-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Improvement of postoperative quality of life in patients with esophageal squamous cell carcinoma: does tea consumption have a role?

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Spatial–temporal-demographic and virological changes of hand, foot and mouth disease incidence after vaccination in a vulnerable region of China

Lived experiences of Palestinian patients with COVID-19: a multi-center descriptive phenomenological study of recovery journey

The impact of COVID-19 lockdowns on physical activity amongst older adults: evidence from longitudinal data in the UK

Factors associated with sexual and reproductive health service utilisation in high migration communities in six Southern African countries

Barriers to and facilitators of accessing HIV services for street-involved youth in Canada and Kenya

Investigating experiences of frequent online food delivery service use: a qualitative study in UK adults